- Home
- DTI vs QNCX Comparison
DTI vs QNCX Comparison
Compare DTI & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTI
- QNCX
- Stock Information
- Founded
- DTI 1984
- QNCX 2012
- Country
- DTI United States
- QNCX United States
- Employees
- DTI N/A
- QNCX N/A
- Industry
- DTI Metal Fabrications
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DTI Industrials
- QNCX Health Care
- Exchange
- DTI Nasdaq
- QNCX Nasdaq
- Market Cap
- DTI 114.9M
- QNCX 92.3M
- IPO Year
- DTI N/A
- QNCX 2019
- Fundamental
- Price
- DTI $3.49
- QNCX $1.89
- Analyst Decision
- DTI Strong Buy
- QNCX Strong Buy
- Analyst Count
- DTI 1
- QNCX 3
- Target Price
- DTI $5.50
- QNCX $9.67
- AVG Volume (30 Days)
- DTI 44.3K
- QNCX 286.7K
- Earning Date
- DTI 11-13-2024
- QNCX 11-13-2024
- Dividend Yield
- DTI N/A
- QNCX N/A
- EPS Growth
- DTI N/A
- QNCX N/A
- EPS
- DTI 0.26
- QNCX N/A
- Revenue
- DTI $149,789,000.00
- QNCX N/A
- Revenue This Year
- DTI $0.09
- QNCX N/A
- Revenue Next Year
- DTI $10.53
- QNCX N/A
- P/E Ratio
- DTI $13.06
- QNCX N/A
- Revenue Growth
- DTI N/A
- QNCX N/A
- 52 Week Low
- DTI $2.43
- QNCX $0.51
- 52 Week High
- DTI $6.36
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- DTI 50.38
- QNCX 52.02
- Support Level
- DTI $3.45
- QNCX $1.80
- Resistance Level
- DTI $3.60
- QNCX $2.09
- Average True Range (ATR)
- DTI 0.13
- QNCX 0.21
- MACD
- DTI -0.00
- QNCX -0.05
- Stochastic Oscillator
- DTI 42.31
- QNCX 27.01
About DTI Drilling Tools International Corporation
Drilling Tools International Corp manufactures, rents, inspects, and refurbishes downhole drilling tools primarily to companies in the oil and natural gas industry for bottom hole assemblies used in onshore and offshore horizontal and directional drilling. The Company's United States operations have locations in Texas, California, Louisiana, Oklahoma, Pennsylvania, North Dakota, New Mexico, Utah, and Wyoming. The Company's international operations are located in Canada with additional stocking points in Europe and the Middle East.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.